Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-25-256666·Foster James Alexander Cunliffe
Schedule 13G ownership disclosure
VIRAX BIOLABS GROUP LTD
Ordinary Shares · CUSIP: G9495L125
Event date: 2024-09-30
- Filing-level shares
- 319,945
- Percent of class
- 7.3%
- James Foster
Shares: 319,945 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-256666
- Form type
- SCHEDULE 13G/A
- Filer
- Foster James Alexander Cunliffe
- CIK
- CIK 1988784
- Filed
- Oct 29, 2025
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership